New research indicates that individuals taking GLP-1 medications for weight loss may decrease their physical activity levels, prompting calls for integrated exercise recommendations.
Posts tagged as “Ozempic”
Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.

